share_log

HC Wainwright & Co. Maintains Buy on Belite Bio, Raises Price Target to $59

Benzinga ·  Nov 6, 2023 11:46

HC Wainwright & Co. analyst Yi Chen maintains Belite Bio (NASDAQ:BLTE) with a Buy and raises the price target from $55 to $59.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment